Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
04 2021
Historique:
revised: 03 03 2021
received: 24 02 2021
accepted: 07 03 2021
pubmed: 30 3 2021
medline: 27 4 2021
entrez: 29 3 2021
Statut: ppublish

Résumé

Many neurological manifestations are associated with COVID-19, including a distinct form of encephalopathy related to cytokine storm, the acute systemic inflammatory syndrome present in a subgroup of COVID-19 patients. Cytokine storm is also associated with immune effector cell-associated neurotoxicity syndrome (ICANS), a complication of chimeric antigen receptor T-cell (CAR-T) therapy, a highly effective treatment for refractory hematological malignancies. We investigated whether COVID-19-related encephalopathy, ICANS, and other encephalopathies associated with cytokine storm, share clinical and investigative findings. Narrative literature review. Comparisons between COVID-19-related encephalopathy and ICANS revealed several overlapping features. Clinically, these included dysexecutive syndrome, language disturbances, akinetic mutism and delirium. EEG showed a prevalence of frontal abnormalities. Brain MRI was often unrevealing. CSF elevated cytokine levels have been reported. A direct correlation between cytokine storm intensity and severity of neurological manifestations has been shown for both conditions. Clinical recovery occurred spontaneously or following immunotherapies in most of the patients. Similar clinical and investigative features were also reported in other encephalopathies associated with cytokine storm, such as hemophagocytic lymphohistiocytosis, sepsis, and febrile infection-associated encephalopathies. COVID-19-related encephalopathy and ICANS are characterized by a predominant electro-clinical frontal lobe dysfunction and share several features with other encephalopathies associated with cytokine storm, which may represent the common denominator of a clinical spectrum of neurological disorders. Therefore, we propose a unifying definition of cytokine storm-associated encephalopathy (CySE), and its diagnostic criteria.

Identifiants

pubmed: 33780166
doi: 10.1002/acn3.51348
pmc: PMC8045903
doi:

Substances chimiques

Receptors, Chimeric Antigen 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

968-979

Informations de copyright

© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Ann Neurol. 2020 Aug;88(2):423-427
pubmed: 32418288
AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2179-90
pubmed: 17110690
J Neurol Neurosurg Psychiatry. 2021 May;92(5):565-566
pubmed: 33158913
Neurol Neuroimmunol Neuroinflamm. 2020 Jul 1;7(5):
pubmed: 32611761
Ital J Pediatr. 2016 Aug 31;42(1):79
pubmed: 27576518
Sci Rep. 2020 Oct 29;10(1):18665
pubmed: 33122776
J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):820-2
pubmed: 25398790
Can J Neurol Sci. 2020 Sep 17;:1-3
pubmed: 32938510
Lancet Rheumatol. 2020 Dec;2(12):e754-e763
pubmed: 33015645
Epilepsia Open. 2020 May 17;5(2):314-324
pubmed: 32537529
J Med Virol. 2020 Oct;92(10):1782-1784
pubmed: 32293714
Brain. 2019 May 1;142(5):1334-1348
pubmed: 30891590
Mediators Inflamm. 2015;2015:792578
pubmed: 25873770
PLoS One. 2012;7(6):e39049
pubmed: 22701747
J Neurol. 2020 Nov;267(11):3121-3127
pubmed: 32533322
Front Neurol. 2020 Oct 19;11:587226
pubmed: 33193051
Pediatr Neurol. 2006 Apr;34(4):315-8
pubmed: 16638510
J Neurol. 2021 Jan;268(1):16-19
pubmed: 32654063
J Neurol. 2021 Mar;268(3):762-769
pubmed: 32749601
Biomed J. 2019 Jun;42(3):178-186
pubmed: 31466711
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Eur J Neurol. 2020 Dec;27(12):2651-2657
pubmed: 32881133
BMC Neurol. 2017 May 25;17(1):103
pubmed: 28545419
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Neurology. 2018 Jul 31;91(5):227-229
pubmed: 29959264
Neurol Neuroimmunol Neuroinflamm. 2020 Jul 29;7(5):
pubmed: 32727813
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
Epilepsia. 2018 Sep;59(9):1753-1763
pubmed: 30132834
Blood. 2017 Mar 23;129(12):1646-1657
pubmed: 28087540
Radiology. 2020 Oct;297(1):E232-E235
pubmed: 32384020
Br J Haematol. 2020 Aug;190(3):e150-e154
pubmed: 32584416
Neurology. 2006 May 9;66(9):1304-9; discussion 1291
pubmed: 16682659
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
J Neuroimmunol. 2020 Dec 15;349:577400
pubmed: 33032013
Neurology. 2020 Sep 8;95(10):445-449
pubmed: 32586897
Neurology. 2012 Apr 10;78(15):1150-6
pubmed: 22422896
Clin Infect Dis. 2005 Oct 15;41(8):1089-96
pubmed: 16163626
Nat Rev Neurol. 2020 Nov;16(11):636-644
pubmed: 32839585
Am Soc Clin Oncol Educ Book. 2019 Jan;39:433-444
pubmed: 31099694
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
pubmed: 16937360
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
Curr Neurol Neurosci Rep. 2018 Oct 2;18(12):82
pubmed: 30280261
Curr Treat Options Neurol. 2017 Jan;19(1):3
pubmed: 28155064
CNS Neurosci Ther. 2021 Jan;27(1):36-47
pubmed: 33381913
Front Neurol. 2020 Nov 05;11:576329
pubmed: 33224090
AJNR Am J Neuroradiol. 2020 Oct;41(10):1800-1803
pubmed: 32732268
Cancer Cell. 2021 Feb 8;39(2):276-283.e3
pubmed: 33508216
Crit Care. 2020 Aug 8;24(1):491
pubmed: 32771053
Neurology. 2020 Aug 18;95(7):e910-e920
pubmed: 32444493
Brain Dev. 2012 Feb;34(2):124-7
pubmed: 21576007
Neuropediatrics. 2013 Oct;44(5):291-4
pubmed: 23794447
Transplant Cell Ther. 2021 Jan;27(1):46-52
pubmed: 33002640
Childs Nerv Syst. 1997 May;13(5):257-63
pubmed: 9224914
Clin Neurophysiol. 2020 Sep;131(9):2265-2267
pubmed: 32736327
Epilepsy Res. 2006 Aug;70 Suppl 1:S263-8
pubmed: 16829046
Intensive Care Med. 2007 May;33(5):798-806
pubmed: 17377766
J Med Virol. 1999 Aug;58(4):420-5
pubmed: 10421411
J Neurol. 2020 Oct 8;:
pubmed: 33030607
Epilepsia. 2011 Nov;52(11):1956-65
pubmed: 21883180
J Neurol Sci. 2020 Aug 15;415:116941
pubmed: 32474220
Epilepsia. 2010 Jul;51(7):1323-8
pubmed: 20345937
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
Gen Hosp Psychiatry. 2020 Jul - Aug;65:47-53
pubmed: 32470824
Epilepsia. 2020 Aug;61(8):e90-e94
pubmed: 32589794
Semin Immunopathol. 2017 Jul;39(5):517-528
pubmed: 28555385
Ann Neurol. 2018 Apr;83(4):739-755
pubmed: 29518260
Neurology. 2015 Oct 6;85(14):1224-32
pubmed: 26341869
Eur J Neurol. 2021 Jan;28(1):248-258
pubmed: 32853434
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Ann Rheum Dis. 2016 Mar;75(3):481-9
pubmed: 26865703
Neurosci Biobehav Rev. 2020 May;112:270-278
pubmed: 32044373
Ann Neurol. 2020 Oct;88(4):860-861
pubmed: 32715524
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
Neurology. 2020 Aug 11;95(6):e767-e772
pubmed: 32439821
J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):289-294
pubmed: 32667036
Mov Disord Clin Pract. 2020 Aug 07;:
pubmed: 32837963
Blood Rev. 2016 Nov;30(6):411-420
pubmed: 27238576
Radiology. 2020 Nov;297(2):E242-E251
pubmed: 32544034
Nat Rev Neurol. 2021 Feb;17(2):65-66
pubmed: 33414554
Am J Hum Genet. 2009 Jan;84(1):44-51
pubmed: 19118815
Neurol Neuroimmunol Neuroinflamm. 2020 May 26;7(5):
pubmed: 32457227
Curr Treat Options Neurol. 2019 Jul 20;21(8):40
pubmed: 31327064
Front Immunol. 2019 Jan 31;10:55
pubmed: 30766533
Epilepsia. 2018 Apr;59(4):739-744
pubmed: 29399791
J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):1004-1006
pubmed: 32651243
J Neurol. 2020 Sep 3;:
pubmed: 32880721
Acta Neurol Scand. 2007 Apr;115(4 Suppl):45-56
pubmed: 17362276
Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S82-9
pubmed: 19932759
Clin Infect Dis. 2021 Jan 04;:
pubmed: 33395482
Lancet. 1983 Jul 9;2(8341):64-7
pubmed: 6134958
Seizure. 2020 Dec;83:234-241
pubmed: 33121875
Biol Blood Marrow Transplant. 2019 Apr;25(4):625-638
pubmed: 30592986
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105212
pubmed: 33066908
J Clin Neurophysiol. 1992 Jan;9(1):145-52
pubmed: 1552002
Chin Med J (Engl). 2018 Apr 5;131(7):776-783
pubmed: 29578120
J Clin Neurosci. 2020 Jun;76:236-237
pubmed: 32307298
Clin Neurophysiol. 2020 Aug;131(8):1928-1930
pubmed: 32615526
J Med Virol. 2021 Jan;93(1):206-222
pubmed: 32558956
Ann Neurol. 2019 Jul;86(1):42-54
pubmed: 31074527
Lancet Respir Med. 2020 Dec;8(12):1233-1244
pubmed: 33075298
Alzheimers Dement. 2016 Jun;12(6):719-32
pubmed: 27179961
Cancer Discov. 2017 Dec;7(12):1404-1419
pubmed: 29025771
PLoS One. 2018 Oct 31;13(10):e0205501
pubmed: 30379898
Acta Neuropathol. 2020 Oct;140(4):583-586
pubmed: 32851506
Sci Rep. 2020 May 7;10(1):7718
pubmed: 32382007
Ann Hematol. 2017 Aug;96(8):1279-1285
pubmed: 28589450
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
Nat Rev Immunol. 2017 Jan;17(1):49-59
pubmed: 27916979
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Brain. 2020 Dec 1;143(12):e102
pubmed: 33064794
Cancer Discov. 2018 Aug;8(8):958-971
pubmed: 29880584
Int J Infect Dis. 2020 Oct;99:47-56
pubmed: 32721533
Brain Behav Immun. 2020 Aug;88:945-946
pubmed: 32283294
Neurochem Int. 2011 Mar;58(4):472-6
pubmed: 21219956
Biomark Res. 2018 Jan 22;6:4
pubmed: 29387417
Brain Pathol. 2021 Jan;31(1):205-210
pubmed: 33002281
J Rheumatol. 2011 Apr;38(4):764-8
pubmed: 21285158
Ann Neurol. 2020 Sep;88(3):626-630
pubmed: 32533727
Cytokine Growth Factor Rev. 2015 Jun;26(3):263-80
pubmed: 25466631
Neurology. 2020 Sep 22;95(12):543-546
pubmed: 32680950
BMC Neurol. 2016 Apr 18;16:49
pubmed: 27089920
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
N Engl J Med. 2021 Jan 7;384(1):20-30
pubmed: 33332779
Ann Neurol. 2016 Dec;80(6):939-945
pubmed: 27770579
J Neurol Sci. 2015 Oct 15;357(1-2):136-42
pubmed: 26198020
Brain Behav Immun. 2020 Jul;87:155-158
pubmed: 32389697
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Nat Rev Neurol. 2012 Oct;8(10):557-66
pubmed: 22986430

Auteurs

Umberto Pensato (U)

Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.

Lorenzo Muccioli (L)

Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.

Ilaria Cani (I)

Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.

Damir Janigro (D)

Department of Physiology, Case Western Reserve University, Cleveland, OH, USA.

Pier Luigi Zinzani (PL)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Istituto di Ematologia "Seragnoli", Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.

Maria Guarino (M)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Pietro Cortelli (P)

Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Francesca Bisulli (F)

Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH